BIODESIX, INC. Fair Value Adjustment of Warrants
BIODESIX, INC. (BDSX) reported Fair Value Adjustment of Warrants of $280.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-05
- BIODESIX, INC. fair value adjustment of warrants for the quarter ending 2025-12-31 was $0.00.
- BIODESIX, INC. fair value adjustment of warrants for the quarter ending 2025-09-30 was $0.00.
- BIODESIX, INC. fair value adjustment of warrants for the quarter ending 2025-06-30 was -$98.00K.
- BIODESIX, INC. fair value adjustment of warrants for the quarter ending 2025-03-31 was $378.00K.
- BIODESIX, INC. fair value adjustment of warrants for fiscal 2025 was $280.00K.
- BIODESIX, INC. fair value adjustment of warrants for fiscal 2023 was $1.27M.
- BIODESIX, INC. fair value adjustment of warrants for fiscal 2022 was -$84.00K.
- BIODESIX, INC. fair value adjustment of warrants for fiscal 2020 was $1.25M, a 1103.85% increase from fiscal 2019.
| Period end | Fair Value Adjustment of Warrants | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 9 month as first filed | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | -$98.00K derived: sum of 3 quarters · filed 2026-08-05 | $280.00K 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$98.00K derived: sum of 2 quarters · filed 2026-08-05 | $280.00K 10-Q · filed 2025-11-03 | |||
| 2025-06-30 | -$98.00K 10-Q · filed 2026-08-05 | $280.00K 10-Q · filed 2026-08-05 | ||||
| 2025-05-08 | $200.00K 10-Q · filed 2026-08-05 | |||||
| 2025-03-31 | $378.00K 10-Q · filed 2026-05-04 | |||||
| 2023-12-31 | -$58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $1.33M derived: sum of 2 quarters · filed 2025-03-03 | $1.33M derived: sum of 3 quarters · filed 2025-03-03 | $1.27M 10-K · filed 2025-03-03 | ||
| 2023-09-30 | $1.39M 10-Q · filed 2024-11-01 | $1.39M derived: sum of 2 quarters · filed 2024-11-01 | $1.33M 10-Q · filed 2024-11-01 | |||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$61.00K 10-Q · filed 2024-08-07 | ||||
| 2023-03-31 | -$61.00K 10-Q · filed 2024-05-08 | |||||
| 2022-12-31 | -$84.00K 10-K · filed 2024-03-01 | |||||
| 2020-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $1.31M derived: sum of 2 quarters · filed 2022-03-14 | $1.30M derived: sum of 3 quarters · filed 2022-03-14 | $1.25M 10-K · filed 2022-03-14 | ||
| 2020-09-30 | $24.00K 10-Q · filed 2021-11-15 | $20.00K derived: sum of 2 quarters · filed 2021-11-15 | -$31.00K 10-Q · filed 2021-11-15 | $31.00K 10-Q · filed 2020-12-10 | ||
| 2020-06-30 | -$4.00K 10-Q · filed 2021-08-10 | -$55.00K 10-Q · filed 2021-08-10 | ||||
| 2020-03-31 | -$51.00K 10-Q · filed 2021-05-11 | |||||
| 2019-12-31 | $104.00K 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |